2 Top Diabetes Stocks to Buy Right Now
In 2019, the diabetes treatment and drug market in the United States reached a landmark valuation of over $15 billion. If you have been thinking about investing in diabetes stocks, there are a few in particular that present particularly attractive buying opportunities at the moment. Since its founding in 1876, Eli Lilly (NYSE: LLY) has remained a kingpin in the pharmaceutical industry, and it boasts a variety of insulins and treatments for diabetes in its product offerings.